You searched for: necroinflammatory (Engelska - Danska)

2 histological response defined as a 2 point decrease in knodell necroinflammatory score from
2 histologisk respons defineret som et 2 points fald i knodells nekroinflammatoriske score ift. forsøgsstart og ingen forværring af knodells fibrosescore.

changes in knodell necroinflammatory and ishak scores were similar for hbeag-positive and hbeag-negative patients.
Ændringer i knodell nekroinflammatorisk og ishak score var tilsvarende for hbeag-positive og hbeag-negative patienter.

2 histological response defined as a ≥ 2 point decrease in knodell necroinflammatory score from baseline with no worsening of the knodell fibrosis score.
2 histologisk respons defineret som et >2 points fald i knodells nekroinflammatoriske score ift. studiestart og ingen forværring af knodells fibrosescore.

high baseline knodell necroinflammatory scores (> 10) were associated with greater histological improvement in nucleoside-naive patients.
høje baseline knodell nekroinflammatoriske scorer (> 10) var forbundet med større histologisk forbedring hos patienter der ikke tidligere havde været i nukleosidbehandling.

response after addition of emtricitabine is excluded (total of 17 subjects across both studies). b knodell necroinflammatory score improvement of at least 2 points without worsening in knodell fibrosis score.
respons efter tillæg af emtricitabin er ekskluderet (i alt 17 forsøgspersoner i begge studier). b forbedring af knodells nekroinflammatoriske score på mindst 2 point uden forværring af knodells fibrosescore.

patients with evaluable baseline histology (baseline knodell necroinflammatory score ≥ 2) b a primary endpoint c roche cobas amplicor pcr assay (lloq = 300 copies/ ml)
patienter med evaluérbar histologi ved baseline (baseline knodell- nekroinflammatorisk score ≥ 2) b et primært endpoint c roche cobas amplicor pcr- assay (lloq = 300 kopier/ ml)